Mariam Seirafi

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

Systematic Review of Effects of Withdrawal of Immunomodulators or Biologic Agents From Patients With Inflammatory Bowel Disease

Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data

Rheumatoid arthritis

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics

Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics

The Search for Causative Environmental Factors in Inflammatory Bowel Disease

Crohn's disease

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

Pregnancy and Breastfeeding in Inflammatory Bowel Disease

[Hepatitis C and insulin resistance].

Factors associated with pregnancy outcome in anti‐TNF treated women with inflammatory bowel disease

Anti-TNF Therapy and Pregnancy in Inflammatory Bowel Disease: A Prospective Cohort Study From the GETAID